Spero Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
60%
€1.22
Target price
31.03.27
€2.10
Performance (%)
-16.83%
End price
14.12.24
€1.02
Summary
This prediction ended on 14.12.24 with a price of €1.02. The price of Spero Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.83%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Spero Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% |
According to BiotechBee what are the pros and cons of Spero Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Spero Therapeutics Inc. diskutieren
Buy mit Kursziel 2,1
In the thread Trading Spero Therapeutics Inc.
Buy beendet

